SEARCH 
COMPANIES
Discover the reality of companies and brands!
TRANSNATIONALE.ORG
Free and independant information on large corporations

Biogen Idec Inc.

Headquarters : 14 Cambridge Center, Cambridge MA 02142 United States of America United States of America web www.biogenidec.com tel. 617-679-2000 stock : BIIB analytics

Brands

name
click to compare prices
» Shop local, ethical and at the best price on Ethishop

« Ethical » rating of Biogen Idec Inc. , group and subsidiaries

Jobs -40% /1998 Offshore 2 Sales 1 Bn $.€ /year Wage 1019 *min. Influence 2
[click on the rating for the method or on the number for the data]

year
business
source
2006Biogen Idec is the fifth-largest biotechnology group in the world.Les Echos
» More business descriptions and market shares for Biogen Idec Inc..
country
address & contact : production type
incentive source
Bermuda Bermuda
Biogen Investments, Ltd :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)
Jersey Jersey
Biotech Manufacturing Limited :
Offshore finance, secret bank account, tax haven, shell companies or free zone(s)

  • Environmental impact

  • Human impact

year name
photo position; compensation
source
2002Bucknum, Thomas
See the photo of: Bucknum, Thomas Vice-president;
2002Kellogg, Peter
See the photo of: Kellogg, Peter Chief Financial Officer;
2002Mullen, James
See the photo of: Mullen, James Chief Executive Officer;
2002Rastetter, William
See the photo of: Rastetter, William Chairman; salary: 0,96 million US$; stock-options: 10,78 million US$;
2002Rohn, William
See the photo of: Rohn, William Vice-president; salary: 0,65 million US$; stock-options: 10,86 million US$;
1981Gilbert, Walter
See the photo of: Gilbert, Walter Chief Executive Officer;
year
employees
<>
social impact : country
source
2005
-650
Internal restructuring: The group cuts 17% of its workforce to save 200 to 300 million dollars per year.: United States of America
Les Echos
2002
995
year
employees
<>
social impact : country
source
 2 informations, access to subscribers

  • Subsidy

  • Advertising & marketing

year  salesincome buybacksource
2004   12million shares
2003   0,68-0,88   billion US$
2002   0,40,15   billion US$
2001   0,270,1   billion US$
2000   0,150,05   billion US$
1999   4million sharesSmartMoney
yearfinancial misdemeanorsalesincomeassetsbuybacksource
 6 informations, access to subscribers
year
purpose : intermediary/lobby : institution
source
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington Post
1999Market admission for genetically modified organisms : EuropaBio : : European Commission translateCorporate Europe Observatory
» More influence from Biogen Idec Inc.
» Influence in 2007
year
purpose : intermediary/lobby : institution
source
 2 informations, access to subscribers
» More influence from Biogen Idec Inc.
» Influence in 2007


Bookmark and Share    en español  en français  in italiano
translate this page in arabic chinese dutch german japanese korean russian
Legal notice © T&C 1999-2010
 CONTRIBUTIONS